Express Pharma

APRIL 8, 2025

In 2023, the company enhanced its Glenview, Illinois facility to meet the rising market need for fluid management systems and virus filtration technologies. We will contribute to the advancement of the pharmaceutical industry as a premium partner that provides innovative and reliable products and services to pharmaceutical companies.

Pharmaceutical Manufacturing

pharmaphorum

JUNE 12, 2025

Skip to main content Thursday 12 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Health and Personal Care Stores

Express Pharma

JUNE 19, 2025

Indian pharmaceutical companies supply more than 60 per cent of global demand for vaccines and over 40 per cent of generic medicines consumed in the United States (2). In FY 2023, India accounted for approximately 27 per cent of all FDA foreign drug inspections, with a notable proportion focused on sterile manufacturing sites.

Documentation

European Pharmaceutical Review

JANUARY 22, 2025

Approval of this drug system for this indication is supported by positive clinical results demonstrating rapid improvement in depressive symptoms compared to placebo, according to the pharmaceutical company. The findings were presented at the 2023 European College of Neuropsychopharmacology Congress (ECNP). At week 4, 22.5

Pharmaceutical Companies

Pharmacy Times

JUNE 24, 2025

This is progressing through a phase 3 trial and includes comparator arms with standard-of-care treatments like daratumumab, bortezomib (Velcade; Millennium/Takeda and Janssen Pharmaceutical Companies), and lenalidomide. 2 We’re still trying to figure out where these new treatments best fit.

Pharmacy Technician

PharmaVoice

JULY 14, 2025

Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Development Library Events Press Releases PharmaVoice 100 Nominate 2024 PV100 2023 PV100 Sign up Search Sign up Search An article from Q&A Need a DTC platform?

Pharmaceutical Companies

Pharmacy Times

JUNE 23, 2025

From 2003 to 2023, 943 drugs were approved through the 505(b)(2) pathway. As of January 1, 2023, CMS has begun issuing unique J-codes to 505(b)(2) drugs dating back to 2003. “In In 2022, based upon a complaint filed by a pharmaceutical company, CMS was asked to reevaluate the SSA section that establishes the J-code,” Soefje said.

Pharmacy Technician

European Pharmaceutical Review

FEBRUARY 17, 2025

billion in 2023/24. Under the new Growth and Skills Levy, employers will be able to allocate funds toward a wider range of training initiatives, including modular courses, short-term programmes, and industry-specific certifications, ensuring companies can equip their workforce with the latest skills in a rapidly evolving landscape.

Pharmaceutical Companies

European Pharmaceutical Review

FEBRUARY 13, 2025

Based on the new cost estimates, pharmaceutical manufacturers in Finland alone will be required to fund 280816 million of these expenses, The directive , enforced on 1 January 2025, imposes an extended manufacturer responsibility on the removal of micro-pollutants from wastewaters.

Pharmaceutical Manufacturing

Pharmaceutical Commerce

JUNE 9, 2025

Ongoing partnership and past supply challenges AstraZeneca has been working hand-in-hand with Sanofi on the production front since its launch in 2023. during the 2024-2025 RSV season compared to the 2022-2023 season, per data presented at the 43rd Annual Meeting of the European Society for Pediatric Infectious Diseases (ESPID).

Drug Pricing

PharmExec

AUGUST 1, 2025

The company also noted that the label update meets an unmet need, with up to 80% of patients with atherosclerotic cardiovascular disease (ASCVD) facing challenges in achieving the LDL-C guideline-recommended target of less than 70 mg/dL. He also explains dark social, how to combat misinformation, closing the trust gap, and more.

Labelling

FDA Law Blog: Biosimilars

JUNE 1, 2025

Government Accountability Office (GAO) published a report finding that, for the years 2016-2018, the pharmaceutical industry spent on average for a sample of 553 drug products approximately $6 billion annually on DTC advertisements, with a significant portion of this spending allocated to television commercials.

Pharmaceutical Companies

pharmaphorum

JUNE 24, 2025

Skip to main content Tuesday 24 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes

pharmaphorum

JUNE 20, 2025

Skip to main content Friday 20 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes

Express Pharma

JUNE 30, 2025

The fact that this single city accounts for roughly one-third of India’s pharmaceutical output and a similar proportion of global vaccine production underscores its role in global health. This prominence isn’t accidental. It’s the outcome of a long-term strategy spearheaded by government policies.

Pharmaceutical Companies

PharmaTech

JULY 4, 2025

Pharmaceutical companies have responded with growing investment in the research and development of novel eye treatments and drug delivery systems designed to address key challenges in ocular therapy. 2023 39 (2), 102-116. link] Gautam, M.; Intracameral Drug Delivery: A Review of Agents, Indications, and Outcomes.

Dosage

Pharmaceutical Technology

JUNE 19, 2025

Innovator oligonucleotide-based drugs targeting central nervous system (CNS) indications witnessed a 339% ($2.17bn) increase in total licensing agreement deal value from 2023 to 2024, reaching a total deal value of $2.81bn, according to GlobalData’s Pharma Intelligence Center Deals Database. Credit: Kateryna Kon via Shutterstock.

Communication

PharmaVoice

JUNE 16, 2025

Either way, reforms to the 340B program, which was created by Congress in 1992 and requires pharmaceutical companies to provide outpatient drug discounts to safety net hospitals, could be on the table.

Hospitals

pharmaphorum

JULY 24, 2025

Skip to main content Thursday 24 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes

pharmaphorum

JUNE 6, 2025

Skip to main content Friday 6 June 2025 twitter linkedin facebook rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes

pharmaphorum

JUNE 17, 2025

Skip to main content Tuesday 17 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes

Pharmaceutical Technology

JUNE 18, 2025

Go deeper with GlobalData Reports Future of Pharma - Looking Ahead to 2023 Reports China Contract Manufacturing Market Outlook - Trends, Ambitions, Ke. Find out more The pharmaceutical sector is at the cornerstone of the BTA. Data Insights The gold standard of business intelligence.

Drug Pricing

BioPharma Dive

JULY 16, 2025

Elevidys is the product of many years of research into the deadly neuromuscular condition and, in 2023 , became the first and currently only gene therapy for the disease approved in the U.S. For Sarepta, the layoffs reflect, in part, uncertainty around the future of Elevidys, its gene therapy for Duchenne muscular dystrophy.

Drug Pricing

Express Pharma

APRIL 2, 2025

For pharmaceutical companies, this creates both opportunity and urgency: drugs that demonstrate clear clinical benefit could gain swift recognition, while those without competitive differentiation may be deprioritised in treatment algorithms.

Biosimilars

Pharmacy Times

AUGUST 5, 2025

Pharmaceutical companies benefit from extended R&D tax incentives and reshoring manufacturing, favoring long-term investment. Critics argue the bill prioritizes pharmaceutical profits, reduces Medicare's negotiation power, and increases inequality in healthcare access. REFERENCES 1. Accessed July 17, 2025.

Pharmacy Technician

Express Pharma

DECEMBER 19, 2024

The 2023 annual report from the Indian Council of Medical Research (ICMR) has raised an alarm (1) , revealing increasing antibiotic resistance for common infections, including urinary tract infections (UTIs), pneumonia, typhoid, and blood infections. Self-medication and unnecessary prescriptions further exacerbate the problem.

Pharmaceutical Companies

pharmaphorum

JULY 24, 2025

Skip to main content Thursday 24 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes

Pharmaceutical Technology

AUGUST 5, 2025

Go deeper with GlobalData Reports State of the Biopharmaceutical Industry 2023 Reports Greece Healthcare (Pharma and Medical Devices) Market Analysis, Reg. Find out more This trade deal puts the pharmaceutical industry at risk of losing between $13bn and $19bn, with consequences that extend beyond short-term financials.

Immunity

BioPharma Dive

JUNE 24, 2025

The company has faced some bumps along the way, including a smaller-than-projected IPO in 2023. But the steady expansion of their use has slowed and, despite much trying, pharmaceutical companies have largely failed to top the drugs’ successes. Earlier this year, it laid off 15% of its workforce.

Drug Pricing

pharmaphorum

JUNE 30, 2025

Skip to main content Monday 30 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes

BioPharma Dive

JUNE 11, 2025

billion buyout of Blueprint Medicines is the sector’s second-largest M&A deal this year and represents the highest value paid for an immune drug developer since April 2023. Sanofi’s $9.1 Sanofi’s $9.1

Drug Pricing

Pharmaceutical Technology

AUGUST 4, 2025

Before Novo arrived as owners, issues at the plant caused a two month-delay for Eylea HD’s FDA approval decision in 2023. Schleifer added in the conference call that the facility was involved in the production of 70 billion doses last year, conducting business “with the vast majority of the top bio-pharmaceutical companies in the world.”

Communication

STAT

JULY 9, 2025

Details on pharmaceutical tariffs “will come at the end of the month,” U.S. The planned tariffs would deal a long-awaited blow to pharmaceutical companies, many of which have pushed back and warned that the levies could drive up costs, deter investments in the U.S., billion in 2021. Merck

Pharmaceutical Companies

pharmaphorum

JULY 7, 2025

Skip to main content Monday 7 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Insurance Coverage and Processing

PharmaVoice

JULY 23, 2025

He was also CEO of La Jolla Pharmaceutical Company from 2011 to 2019, leading the development of a blood pressure drug that failed to meet sales expectations. Despite past criticism of public health policies, Tidmarsh recently praised the FDA and said he’ll focus on boosting review efficiencies.

Communication

Pharmaceutical Technology

JUNE 27, 2025

It feels like in the US, pharmaceutical companies are capitalising on people’s frustration and desperation to lose weight.” Telehealth platforms selling compounded GLP-1RAs flourished in 2023 and 2024 amid shortages of semaglutide and later tirzepatide.

Drug Pricing

pharmaphorum

JULY 14, 2025

Skip to main content Monday 14 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes